DelfaGLP-1 Atlas

Lead sponsor

Eccogene

5 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.

5

Trials led

1

Active

336

Total enrollment

22

Sites

Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.

Portfolio

How this sponsor's trials break down

Trials by phase

Phase 1
4
Phase 2
1

Trials by status

Not yet recruiting
1
Completed
4

Trials led

MIST (Metabolic Intervention With Semaglutide and THR-β Therapy) TrialBMI ≥30Ph 2Not yet recruiting160
FTIH of ECC5004 in Healthy and Diabetic ParticipantsBMI 18-32Ph 1Completed69
ECC5004 DDI Study With Atorvastatin, Rosuvastatin, Digoxin and Midazolam in Healthy ParticipantsBMI 18-32Ph 1Completed48
A Phase Ib Study of AZD5004 in Chinese Participants With Overweight/Obesity With or Without Type 2 Diabetes MellitusBMI ≤35Ph 1Completed45
ECC5004 RBA FE Study in Healthy ParticipantsBMI 18-32Ph 1Completed14